100% Export Oriented Unit of a wide range of products which include mounjaro-5mg/0.5ml (tirzepatide) solution for injection, 0.25 mg wegovy semaglutide injection, 1.7 mg wegovy semaglutide injection, 1 mg wegovy semaglutide injection and 0.5 mg wegovy semaglutide injection.
Mounjaro-5mg/0.5ml (tirzepatide) Solution For Injection
Mounjaro 5mg/0.5ml (tirzepatide) is a prescription, once-weekly, subcutaneous injection used to improve blood sugar control in type 2 diabetes and for chronic weight management in adults. Acting as a dual GIP and GLP-1 receptor agonist, it enhances insulin release, slows gastric emptying, and reduces hunger
For injection dosage form (Wegovy® solution): For weight management and lowering the risk of heart attack or stroke: Adults and children 12 years of age and older—At first, 0.25 milligrams (mg) injected under the skin once a week for 4 weeks. Your doctor may increase your dose every 4 weeks
Wegovy 1mg FlexTouch helps reduce the risk of major heart events, such as heart attack, stroke, and cardiovascular death, in obese or overweight adults with heart disease. It promotes weight loss and improves metabolic health and lipid profile, contributing to better heart health.
Wegovy 0.5mg FlexTouch helps reduce the risk of major heart events, such as heart attack, stroke, and cardiovascular death, in obese or overweight adults with heart disease. It promotes weight loss and improves metabolic health and lipid profile, contributing to better heart health.
Alina Tradelink Block No. 01, GR. Floor, House No. 806 Plot No. 43, W. No. 53, Bhosle Wadi, DR Ambedkar Road, Lashkari Bagh, Below Life Line Hospital Nagpur - 440017, Maharashtra, India
